热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　10月7日消息，港股生物医药股开盘下挫，金斯瑞生物跌超15%，再鼎医药跌超7%，泰格医药、君实生物跌超6%，荣昌生物、诺诚健华跌超4%。

　　渤海证券指出，近期AI制药催化密集，行业焦点逐步从模型能力转向湿实验验证效率等方面，建议关注AI制药相关基因合成、蛋白表达、试剂耗材、动物模型及临床试验等细分赛道的投资机遇。同时，2026年ESMO年会即将召开，优异临床数据有望读出，带来板块密集催化，建议关注创新药、CXO及生命科学上游产业链等的投资机遇。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.